Answers are grounded in this paper and cite their sources.
In this trial involving patients with advanced heart failure who were ineligible for heart transplantation, a small, intrapericardial, centrifugal-flow LVAD was found to be noninferior to an axial-flow LVAD with respect to survival free from disabling stroke or device removal for malfunction or failure. (Funded by HeartWare; ENDURANCE ClinicalTrials.gov number, NCT01166347 .).
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: